(Q39510747)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

'Makes you wanna do treatment': benefits of a hepatitis C specialist clinic to clients in Christchurch, New Zealand (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Elena Cama

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Carla Treloar

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

2

Rebecca Gray

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

Health & Social Care in the Community

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

216-223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

Stigma, discrimination and the health of illicit drug users

19 February 2020

cites work

1 reference

Boceprevir for previously treated chronic HCV genotype 1 infection

21 January 2018

1 reference

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach

21 January 2018

1 reference

Hepatitis C treatment experiences and decision making among patients living with HIV infection.

21 January 2018

1 reference

Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach.

21 January 2018

1 reference

Stigma in the context of hepatitis C: concept analysis

21 January 2018

1 reference

21 January 2018

1 reference

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

21 January 2018

1 reference

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users

21 January 2018

1 reference

Barriers to accessing care in patients with chronic hepatitis C: the impact of depression

21 January 2018

1 reference

A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment

21 January 2018

1 reference

Understanding and evaluating qualitative research

21 January 2018

1 reference

Global burden of disease (GBD) for hepatitis C.

21 January 2018

1 reference

Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.

21 January 2018

1 reference

Telaprevir for previously untreated chronic hepatitis C virus infection

21 January 2018

1 reference

Limited uptake of hepatitis C treatment among injection drug users

21 January 2018

1 reference

Psychiatric barriers to readiness for treatment for hepatitis C Virus (HCV) infection among injection drug users: clinical experience of an addiction psychiatrist in the HIV-HCV coinfection clinic of a public health hospital

21 January 2018

1 reference

The costs of not treating hepatitis C virus infection in injecting drug users in New Zealand

21 January 2018

1 reference

Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.

21 January 2018

1 reference

Integrating HCV services for drug users: a model to improve engagement and outcomes

21 January 2018

1 reference

The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone

21 January 2018

1 reference

The lived experience of men and women with hepatitis C: implications for support needs and health information.

21 January 2018

1 reference

Theorising stigma and the experiences of injecting drug users in Australia

21 January 2018

1 reference

Drug treatment clients' readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings

21 January 2018

1 reference

Infection control in the context of hepatitis C disclosure: implications for education of healthcare professionals

21 January 2018

1 reference

Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HSC.12009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23199074%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference